common side effects of kazano
lactic acidosis
nausea
vomiting
hypoglycemia
other side effects
upper respiratory tract infection
abdominal distress
headache
nasopharyngitis
comprehensive list of adverse effects
common adverse reactions
upper respiratory tract infection
nasopharyngitis
diarrhea
hypertension
headache
pain
urinary tract infection
alogliptin-metformin
diarrhea
gastroenteritis
abdominal pain
vomiting
gastritis
gastroesophageal reflux disease alogliptin
diarrhea
abdominal pain
gastroesophageal reflux disease
pancreatitis postmarketing reports
acute pancreatitismetformin
diarrhea
nausea/vomiting
flatulence
indigestion
abdominal discomfort
acute pancreatitis
dpp
inhibitors
pooled analysis of studies
overall rate of pancreatitis
alogliptin mg
mg
active control
placebo
events per patient years
alogliptin
postmarketing reports
hepatic enzyme elevations
fulminant hepatic failuremetformin
hepatitis
liver function test abnormalities
cases of hepatic dysfunction
hepatic failure
postmarketing period with alogliptin-treated patients
causality
alogliptin-metformin
hypoglycemiaalogliptin
hypoglycemia metformin
hypoglycemia
loss of appetitevery
lactic acidosis
vitamin b deficiency
metformin-treated patients
lactic acidosis
cases per patient-years
cases
fatalities
patient-years exposure in clinical trials
cases of lactic acidosis
reported cases
patients with significant renal insufficiency
setting of multiple concomitant medical/surgical problems
multiple concomitant medications
alogliptin monotherapy study
incidence of hypoglycemia
placebo
adding alogliptin
glyburide
insulin
incidence of hypoglycemia
placebo
elderly patients
incidence of hypoglycemia
alogliptin
glipizide
week
placebo-controlled study of alogliptin
metformin regimen
hypoglycemic events
patients in the alogliptin-metformin group
placebo group
alogliptin
hypersensitivity reactions
postmarketing reports
anaphylaxis
angioedema
rash
urticaria
severe cutaneous adverse reactions
stevens-johnson syndrome
erythema multiforme
postmarketing reports of bullous pemphigoid
requiring hospitalization
dipeptidyl peptidase
inhibitors
case
systemic immunosuppressive treatment
discontinuation of dpp
inhibitor
pruritus
rashalogliptin
pruritus
rashpostmarketing reports
exfoliative skin conditions
stevens-johnson syndrome
angioedema
urticariametformin
erythema
pruritus
urticariadipeptidyl peptidase
inhibitors
postmarketing reports
bullous pemphigoid
alogliptin-metformin
upper
respiratory tract infection
nasopharyngitis alogliptin
nasopharyngitis
upper respiratory tract infection metformin
upper
respiratory tract infection
nasopharyngitis
alogliptin-metformin
headache alogliptin
headache metformin
headache
metallic taste
alogliptin-metformin
hypertension alogliptin
hypertension frequency
heart failuremetformin
hypertension
clinical trial in patients with recent acute coronary syndrome
greater proportion of patients
drug
congestive heart failure
placebo
n
n =]
alogliptin-metformin
urinary tract infection alogliptin
urinary tract infection metformin
urinary tract infection
october
december
cases of severe arthralgia
fda
adverse event reporting system database
case
use
more dipeptidyl peptidase
inhibitor
cases
substantial reduction in prior activity level
patients
disabling
disabling joint pain
cases
symptoms
month
starting therapy
cases symptoms
month after discontinuation
positive rechallenge
cases
cases
involving use of a different dpp
inhibitor
sitagliptin
greatest number of cases
n =-rrb-
saxagliptin
n =-rrb-
linagliptin
n =-rrb-
alogliptin
n =-rrb-
vildagliptin
n =-rrb-
alogliptin-metformin
pain alogliptin
painfrequency
arthralgia metformin
pain
metformin
asthenia
blurred vision
dizziness
headache
nervousness
pounding in the ears
fast heartbeat
anxiety
bladder pain
cloudy urine
chest pain
chills
cold sweats
coma
confusion
cool, pale skin
decreased urine output
depression
burning
painful urination
dilated neck veins
extreme fatigue
frequent urge
increased hunger
irregular breathing
irregular heartbeat
side pain
nausea
nightmares
seizures
shakiness
slurred speech
swelling of the face
fingers
feet
lower legs
tightness in chest
troubled breathing
unusual tiredness
weakness
weight gain
blistering
peeling
loosening of the skin
bloating
constipation
cough
darkened urine
diarrhea
difficulty with swallowing
fever
hives or itching
indigestion
muscle pain
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
loss of appetite
pains in the stomach
side
abdomen
radiating
back
puffiness
swelling of the eyelids
eyes
face
lips
tongue
red skin lesions
purple center
red, irritated eyes
sore throat
sores
ulcers
white spots in the mouth
lips
vomiting
yellow eyes
skin
dark-colored urine
general feeling of tiredness
weakness
light-colored stools
redness of the skin
severe joint pain
stomach pain, continuing
welts
body aches
pain
ear congestion
loss of voice
muscle aches
sneezing
runny nose
back pain